glp-1 function Frontiers GLP-1 Receptor Agonists and the

Electronic supplementary material 13058_2008_2172_MOESM1_ESM.ppt (download PPT Additional file 1: Powerpoint file showing the growth inhibitory effect of buthionine sulfoximine (BSO) and 17-estradiol (E 2 ) in MCF-7:2A cells is reversed by the antiestrogen 4-hydroxytamoxifen (4-OHT)

Short-acting RAs, such as exenatide (Byetta), lixisenatide and beinaglutide, have a duration of action of only a few hours after being subcutaneously injected., thus need multiple times injection daily

Overall, the newer small molecule GLP-1 RAs such as danuglipron and orforglipron have shown significant reductions in HbA1c and body weight, comparable to existing GLP-1 RAs

However, the researchers noted that a definitive causal relationship between the medications and hair loss has not been established